Drugs / Resorcinol
last change Aug 2026 re-read 2 minutes ago

Resorcinol

Small molecule

Developed for
actinic keratosis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04429308 Comparator Aug 2026 → Dec 2027 expected actinic keratosis Northwestern University Not yet recruiting No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Resorcinol “Chemical peels consists of a combination of Jessner's Solution: Composed of Salicylic Acid (14%), Medical Grade Lactic Acid (14%), Medical Grade Resorcinol (14%), Denatured...” NCT04429308
Known as Benzene-1,3-diol ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as C.i. oxidation base 31 ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as C.I.-76505 ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as FEMA NO. 3589 ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as NSC-1571 ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as Resorcin ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as Resorcinum ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Known as Tilloderm ChEMBL registry synonym — accepted as the source's own label CHEMBL24147
Modality Small molecule CHEMBL24147